Francesca Fiorentino
1, 2
, BSc, MSc, PhD ;
Denys Prociuk
1
, BSc, MSc ;
Ana Belen Espinosa Gonzalez
1
, MSc, PhD ;
Ana Luisa Neves
3
, MSc, MD, PhD ;
Laiba Husain
4
, BSc, MPH ;
Sonny Christian Ramtale
1
, BSc, MSc ;
Emma Mi
1
, MBBChir ;
Ella Mi
1
, MBBChir ;
Jack Macartney
4
;
Sneha N Anand
4
, BSc, MSc, PhD ;
Julian Sherlock
4
, BA ;
Kavitha Saravanakumar
5
, BSc, MSc ;
Erik Mayer
1
, PhD ;
Simon de Lusignan
4, 6
, MBBS, MSc, MD ;
Trisha Greenhalgh
4
, MA, MBA, MD, PhD ;
Brendan C Delaney
1
, MD
1
Department of Surgery and Cancer, Imperial College London, London, United Kingdom
2
Imperial Clinical Trials Unit, Imperial College London, London, United Kingdom
3
Patient Safety Translational Research Centre, Institute of Global Health Innovation, Imperial College London, London, United Kingdom
4
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom
5
Whole Systems Integrated Care, North West London Collaboration of Clinical Commissioning Group, London, United Kingdom
6
Royal College of General Practitioners Research and Surveillance Centre, London, United Kingdom
Corresponding Author:
-
Francesca Fiorentino, BSc, MSc, PhD
-
Department of Surgery and Cancer
-
Imperial College London
-
Queen Elizabeth the Queen Mother Building (10th Floor/1091), St Mary's Hospital
-
Praed Street
-
London, W2 1NY
-
United Kingdom
-
Phone:
44 2033123761
-
Email: f.fiorentino@imperial.ac.uk